Arylsulfonamide 64B

Research use only, not for human use.

Arylsulfonamide 64B (HIF inhibitor 64B) is a small molecule HIF pathway inhibitor.

Arylsulfonamide 64B (HIF inhibitor 64B) is a small molecule HIF pathway inhibitor, blocks hypoxia-induced expression of c-Met and CXCR4 and uveal melanoma (UM) cell migration; blocks HIF-1α association with co-factors p300 and CBP at low micromolar concentrations, disrupts the HIF transcription complex by interfering with HIF-1α recruitment of p300/CBP co-factors on hypoxia-responsive elements on target genes; demonstrates strong anti-cancer activity in syngeneic and xenogeneic orthotopic UM mouse models, Arylsulfonamide 64B (64B) is a potent inhibitor of the hypoxiainduced CXCR4 and c-Met-mediated signaling axis that controls in vitro tumor cell motility; shows potent anti-tumor activity at the primary melanoma growth site in the eye, reduces circulating tumor cells, and strongly inhibits spontaneous formation and expansion of metastases in the liver with minimal toxicity.

——

——

HIF inhibitor 64B

Angiogenesis

HIF/HIF Prolyl-hydroxylase

HIF/HIF Prolyl-hydroxylase

——

——

1342890-83-8

444.546

C23H28N2O5S

>98% (HPLC)

——

CC1(C=CC2=C(O1)C=CC(=N2)CN(C3CCC3)S(=O)(=O)C4=CC(=C(C=C4)OC)OC)C

N-cyclobutyl-N-((2,2-dimethyl-2H-pyrano[3,2-b]pyridin-6-yl)methyl)-3,4-dimethoxybenzenesulfonamide

(-20℃)

With Ice Pack

≥ 2 years